Trials / Completed
CompletedNCT01708304
Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 510 (actual)
- Sponsor
- University of Washington · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The University of Washington's Northwest Research Group on Aging is partnering with Area Agencies on Aging (AAA) in Washington and Oregon to complete this translational investigation of RDAD (Reducing Disabilities in Alzheimer's Disease). RDAD is an evidence-based program with demonstrated efficacy in helping older adults with dementia maintain physical function and remain physically and mentally healthy. This study asks two questions: 1) Can AAA partners successfully translate and implement RDAD, and 2) Is AAA implementation of RDAD effective in producing desired outcomes among agencies, providers, and older adults with dementia and their family members. This study is being conducted in Washington and Oregon states.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | RDAD | Exercise training for caregiver and care recipient. Behavioral modification training for caregiver. |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2012-10-16
- Last updated
- 2017-09-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01708304. Inclusion in this directory is not an endorsement.